102: Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort

Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort Music:Enjoy the music based on this article at the end of the episode. Support:Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00 More at basebybase.com On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics. Episode link: https://basebybase.com/episodes/clinical-impact-of-pharmacogenetic-risk-variants-in-a-large-chinese-cohort Chapters (00:00:14) - Patients' genetics: How their genes affect their treatment(00:02:18) - What is pharmacogenetics?(00:03:38) - Taiwan Precision Medicine Initiative study(00:06:10) - PGX risk variants in the US(00:10:50) - PGX studies: The complexity, limitations, and implications